Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Volker Thiel

Showing results (151-160 of 175) with videos related to

Pageof 18
Sort By:
Mbio|January 10, 2023
The Substitutions L50F, E166A, and L167F in SARS-CoV-2 3CLpro Are Selected by a Protease Inhibitor <i>In Vitro</i> and Confer Resistance To NirmatrelvirDirk Jochmans, Cheng Liu, Kim Donckers, et al.
Nature Communications|April 22, 2023
Rhinovirus-induced epithelial RIG-I inflammasome suppresses antiviral immunity and promotes inflammation in asthma and COVID-19Urszula Radzikowska, Andrzej Eljaszewicz, Ge Tan, et al.
Virus Research|October 15, 2018
Host switching pathogens, infectious outbreaks and zoonosis: A Marie Skłodowska-Curie innovative training network (HONOURs)Lia van der Hoek, Ernst Verschoor, Martin Beer, et al.
Plos Pathogens|February 4, 2017
Early endonuclease-mediated evasion of RNA sensing ensures efficient coronavirus replicationEveline Kindler, Cristina Gil-Cruz, Julia Spanier, et al.
Journal of Virology|September 18, 2015
Evidence for an Ancestral Association of Human Coronavirus 229E with BatsVictor Max Corman, Heather J Baldwin, Adriana Fumie Tateno, et al.
Nature Communications|December 15, 2021
Convergent use of phosphatidic acid for hepatitis C virus and SARS-CoV-2 replication organelle formationKeisuke Tabata, Vibhu Prasad, David Paul, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 9, 2025
Mycophenolic acid treatment drives the emergence of novel SARS-CoV-2 variantsToni Luise Meister, Maximilian K Nocke, Natalie Heinen, et al.
Plos Pathogens|June 24, 2022
Correction: Recombinant Lloviu virus as a tool to study viral replication and host responsesAdam J Hume, Baylee Heiden, Judith Olejnik, et al.
Plos Pathogens|November 3, 2011
The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitorsSusanne Pfefferle, Julia Schöpf, Manfred Kögl, et al.
Plos Pathogens|February 4, 2022
Recombinant Lloviu virus as a tool to study viral replication and host responsesAdam J Hume, Baylee Heiden, Judith Olejnik, et al.
Pageof 18

Showing results (151-160 of 175) with videos related to

Sort By:
Pageof 18
Mbio|January 10, 2023
The Substitutions L50F, E166A, and L167F in SARS-CoV-2 3CLpro Are Selected by a Protease Inhibitor <i>In Vitro</i> and Confer Resistance To NirmatrelvirDirk Jochmans, Cheng Liu, Kim Donckers, et al.
Nature Communications|April 22, 2023
Rhinovirus-induced epithelial RIG-I inflammasome suppresses antiviral immunity and promotes inflammation in asthma and COVID-19Urszula Radzikowska, Andrzej Eljaszewicz, Ge Tan, et al.
Virus Research|October 15, 2018
Host switching pathogens, infectious outbreaks and zoonosis: A Marie Skłodowska-Curie innovative training network (HONOURs)Lia van der Hoek, Ernst Verschoor, Martin Beer, et al.
Plos Pathogens|February 4, 2017
Early endonuclease-mediated evasion of RNA sensing ensures efficient coronavirus replicationEveline Kindler, Cristina Gil-Cruz, Julia Spanier, et al.
Journal of Virology|September 18, 2015
Evidence for an Ancestral Association of Human Coronavirus 229E with BatsVictor Max Corman, Heather J Baldwin, Adriana Fumie Tateno, et al.
Nature Communications|December 15, 2021
Convergent use of phosphatidic acid for hepatitis C virus and SARS-CoV-2 replication organelle formationKeisuke Tabata, Vibhu Prasad, David Paul, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 9, 2025
Mycophenolic acid treatment drives the emergence of novel SARS-CoV-2 variantsToni Luise Meister, Maximilian K Nocke, Natalie Heinen, et al.
Plos Pathogens|June 24, 2022
Correction: Recombinant Lloviu virus as a tool to study viral replication and host responsesAdam J Hume, Baylee Heiden, Judith Olejnik, et al.
Plos Pathogens|November 3, 2011
The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitorsSusanne Pfefferle, Julia Schöpf, Manfred Kögl, et al.
Plos Pathogens|February 4, 2022
Recombinant Lloviu virus as a tool to study viral replication and host responsesAdam J Hume, Baylee Heiden, Judith Olejnik, et al.
Pageof 18